Main Barriers to States Expanding Medicaid
Even though Medicaid coverage varies greatly from state to state, now under the Affordable Care Act’s option to expand the program, there are ways the public and private sectors can cooperate to provide care, Leah Binder said. Maternity care is a good example since Medicaid pays for half of the births in the United States and the other half are purchasers. But both sides are concerned about the rise in the rate of caesarean sections across the country.
“If we start aligning and working together on these issues, I think there can be some real progress,” she said. “And that’s regardless of the expansion. That can happen in any state.”
Meanwhile, Austin Frakt, PhD wondered how much the hesitation to expand Medicaid, which mostly occurred in red states, is a result of politicians waiting for a change in the administration. Matt Salo admitted that the top reason why states haven’t expanded the program is political, and pushback tends to come from the state house of representatives.
The second reason states haven’t expanded Medicaid is financial, and third is ideological. States are trying to figure out how to structure Medicaid expansion so that it makes sense for their residents. That’s why some states, such as Arkansas, Indiana, Iowa, and Michigan, have gone a different route with their expansion plans.
“How do you create a program that meets the ideological needs of people who think differently about healthcare?” Salo asked. “How do you engage the consumer in a different way than Medicaid traditionally has?”
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More